CSIMarket
 


Pro Dex Inc  (PDEX)
Other Ticker:  
 
 

PDEX's Capital Expenditures Growth by Quarter and Year

Pro Dex Inc's Capital Expenditures results by quarter and year




PDEX Capital Expenditures (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter June - 0.34 0.10 0.09
III Quarter March - 0.51 0.10 0.18
II Quarter December 0.26 0.08 0.58 0.05
I Quarter September 0.06 0.48 0.15 0.33
FY   0.32 1.41 0.93 0.65



PDEX Capital Expenditures second quarter 2020 Y/Y Growth Comment
Pro Dex Inc achieved in the second quarter, above Company average Capital Expenditures surge of 220% year on year, to $ 0.26 millions.

Among companies who have reported second quarter results in the Medical Equipment & Supplies industry only one Company has achieved higher year on year Capital Expenditures results in the second quarter. While Pro Dex Inc' s Capital Expenditures doubling of 220% ranks overall at the positon no. 78 in the second quarter.




PDEX Capital Expenditures ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter June - 240 % 11.11 % -60.87 %
III Quarter March - 410 % -44.44 % 100 %
II Quarter December 220 % -86.21 % 1060 % 150 %
I Quarter September -87.5 % 220 % -54.55 % -
FY   - 51.61 % 43.08 % 91.18 %

Financial Statements
Pro Dex Inc's second quarter 2020 Capital Expenditures $ 0.26 millions PDEX's Income Statement
Pro Dex Inc's second quarter 2019 Capital Expenditures $ 0.08 millions Quarterly PDEX's Income Statement
New: More PDEX's historic Capital Expenditures Growth >>


PDEX Capital Expenditures (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter June - -33.33 % 0 % -50 %
III Quarter March - 537.5 % -82.76 % 260 %
II Quarter December 326.67 % -83.33 % 286.67 % -84.85 %
I Quarter September -82.35 % 380 % 66.67 % 43.48 %
FY (Year on Year)   - 51.61 % 43.08 % 91.18 %




Capital Expenditures second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #2
Healthcare Sector #11
Overall #78

Capital Expenditures Y/Y Growth Statistics
High Average Low
172.36 % 23.04 % -73.21 %
(June 30. 2016)   (Dec 31 2015)
Capital Expenditures second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #2
Healthcare Sector #11
Overall #78
Capital Expenditures Y/Y Growth Statistics
High Average Low
172.36 % 23.04 % -73.21 %
(June 30. 2016)   (Dec 31 2015)

Capital Expenditures by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Pro Dex Inc's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
2000 % 161.96 % -93.75 %
(Dec 31 2015)  


PDEX's II. Quarter Q/Q Capital Expenditures Comment
Pro Dex Inc achieved in the II. Quarter 2020 above company average sequential Capital Expenditures doubling of 326.67%, to $ 0.26 millions, from $0.06 millions in the first quarter.
PDEX is impressively improving, not only recording higher then normal gain, but also increasing rate, Ian M. Edwards, Healthcare sector advisor allocated in Seattle said.

Within Medical Equipment & Supplies industry Pro Dex Inc achieved highest sequential Capital Expenditures growth. While Pro Dex Inc's Capital Expenditures growth quarter on quarter, overall rank is 10.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #1
Healthcare Sector #2
Overall #10
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #1
Healthcare Sector #2
Overall #10
Capital Expenditures Q/Q Growth Statistics
High Average Low
2000 % 161.96 % -93.75 %
(Dec 31 2015)  


PDEX's II. Quarter Q/Q Capital Expenditures Comment
Pro Dex Inc achieved in the II. Quarter 2020 above company average sequential Capital Expenditures doubling of 326.67%, to $ 0.26 millions, from $0.06 millions in the first quarter.
Pro Dex Inc is undergoing a remarkable growth, not only reporting better then average gain, and also improving speed, Ian M. Edwards, Healthcare sector advisor allocated in Seattle said.

Within Medical Equipment & Supplies industry Pro Dex Inc achieved highest sequential Capital Expenditures growth. While Pro Dex Inc's Capital Expenditures growth quarter on quarter, overall rank is 10.


Pro Dex Inc's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
Cumulative Capital Expenditures 12 Months Ending $ 1.16 $ 0.98 $ 1.40 $ 1.16 $ 0.76
Y / Y Capital Expenditures Growth (TTM) 52.76 % -22.31 % 49.68 % 26.72 % -23.23 %
Year on Year Capital Expenditures Growth Overall Ranking # 77 # 1263 # 711 # 1063 # 2284
Seqeuential Capital Expenditures Change (TTM) 18.23 % -29.76 % 20.31 % 52.89 % -39.87 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 254 # 2503 # 542 # 170 # 2997




Cumulative Capital Expenditures growth Comment
Although Pro Dex Inc's Annual Capital Expenditures growth year on year were below company's average 116.43% , Capital Expenditures announced in the Dec 31 2019 period, show improvement in Capital Expenditures trend, to cumulative trailing twelve month growth of 52.76% year on year, from -22.31% in Sep 30 2019. Pro Dex Inc had also the second highest Capital Expenditures rise in Medical Equipment & Supplies industry.

Among companies within the Healthcare sector 6 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 77, from total ranking in previous quarter at 1263.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
172.36 %
23.04 %
-73.21 %
(June 30. 2016)  

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 2
Healthcare Sector # 7
Overall # 77

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
1048.33 %
116.43 %
-83.78 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 33
S&P 500 # 253
Cumulative Capital Expenditures growth Comment
Although Pro Dex Inc's Annual Capital Expenditures growth year on year were below company's average 116.43% , Capital Expenditures announced in the Dec 31 2019 period, show improvement in Capital Expenditures trend, to cumulative trailing twelve month growth of 52.76% year on year, from -22.31% in Sep 30 2019. Pro Dex Inc had also the second highest Capital Expenditures rise in Medical Equipment & Supplies industry.

Among companies within the Healthcare sector 6 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 77, from total ranking in previous quarter at 1263.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
172.36 %
23.04 %
-73.21 %
(June 30. 2016)  


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 2
Healthcare Sector # 7
Overall # 77

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
1048.33 %
116.43 %
-83.78 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 33
S&P 500 # 253




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
PDEX's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for PDEX's Competitors
Capital Expenditures Growth for Pro Dex Inc's Suppliers
Capital Expenditures Growth for PDEX's Customers

You may also want to know
PDEX's Annual Growth Rates PDEX's Profitability Ratios PDEX's Asset Turnover Ratio PDEX's Dividend Growth
PDEX's Roe PDEX's Valuation Ratios PDEX's Financial Strength Ratios PDEX's Dividend Payout Ratio
PDEX's Roa PDEX's Inventory Turnover Ratio PDEX's Growth Rates PDEX's Dividend Comparisons



Companies with similar Capital Expenditures rise for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Dec 31 2019
Lifevantage Corp  373.66 %$ 373.656 millions
Pluristem Therapeutics Inc  362.50 %$ 362.500 millions
Urovant Sciences Ltd.  361.29 %$ 361.290 millions
Dynatronics Corp  346.10 %$ 346.102 millions
Applied Genetic Technologies Corp  287.06 %$ 287.059 millions
Pro Dex Inc  232.47 %$ 232.468 millions
Brookdale Senior Living Inc.  224.80 %$ 224.802 millions
Bio-techne Corp  216.33 %$ 216.334 millions
Regeneron Pharmaceuticals, Inc.  205.05 %$ 205.048 millions
Seattle Genetics Inc  202.48 %$ 202.485 millions
Abbvie inc.  157.72 %$ 157.724 millions
Intuitive Surgical, Inc.  155.86 %$ 155.856 millions
Dexcom, Inc.  149.15 %$ 149.153 millions
Protokinetix, Inc.  147.66 %$ 147.657 millions
Electromed, Inc.  139.88 %$ 139.884 millions
Masimo Corp  137.56 %$ 137.557 millions
Zimmer Biomet Holdings, Inc.  132.42 %$ 132.421 millions
Genocea Biosciences, Inc.  117.91 %$ 117.910 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SNA's Profile

Stock Price

SNA's Financials

Business Description

Fundamentals

Charts & Quotes

SNA's News

Suppliers

SNA's Competitors

Customers & Markets

Economic Indicators

SNA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071